News >

Exciting Advances Continue in HER2+ Breast Cancer and Other Subtypes

Jessica Hergert
Published: Wednesday, Nov 20, 2019

Kurt W. Tauer, MD, FACP, hematologist/medical oncologist, associate professor, Department of Hematology/Oncology, at the University of Tennessee Health Science Center, senior partner and chief of staff of West Cancer Center

Kurt W. Tauer, MD, FACP

On the heels of the 2019 ESMO Congress, encouraging updates that read out in HER2-positive breast cancer, as well as hormone receptor–positive disease, may foreshadow more practice-changing data on the horizon, said Kurt W. Tauer, MD, FACP.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication